DMAC vs H · $157.4M cap vs rev $6.65B
DiaMedica Therapeutics Inc (DMAC) versus Hyatt Hotels Corporation (H) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Hyatt Hotels Corporation (H) is a lodging company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported H revenue for 2024-12-31 was $6.65B. Net income was $1.30B. Revenue was down 0.3% from 2023-12-31 to 2024-12-31. H currently screens at market cap $17.08B.
DMAC currently screens at market cap $157.4M. H currently screens at market cap $17.08B.
Not investment advice. Open the DMAC and H stock pages for the full models.
Not investment advice.